ALBERT D MASON INC

Position in GILD — Gilead Sciences, Inc.

CIK 1169318 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$633,216

-$65,306 QoQ

Shares Held

5,012

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#1,274

of 2,275 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ALBERT D MASON INC holds $5,081,052 across 3 Drug Manufacturers - General names. GILD ranks #2 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	25,727	$4,031,935
2	GILD	Gilead Sciences, Inc. This page	5,012	$633,216
3	BMY	Bristol Myers Squibb Co	7,218	$415,901

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$633,216	5,012	0.0%	Shares	Sole	2026-07-22
2026-03-31	$698,522	5,012	-2.3%	Shares	Sole	2026-04-15
2025-12-31	$629,901	5,132	-0.4%	Shares	Sole	2026-01-13
2025-09-30	$571,761	5,151	-2.1%	Shares	Sole	2025-10-15
2025-06-30	$583,287	5,261	-3.7%	Shares	Sole	2025-07-29
2025-03-31	$612,241	5,464	-7.0%	Shares	Sole	2025-04-16
2024-12-31	$542,581	5,874	-0.3%	Shares	Sole	2025-01-15
2024-09-30	$494,152	5,894	-2.2%	Shares	Sole	2024-10-22
2024-06-30	$413,306	6,024	-1.6%	Shares	Sole	2024-07-16
2024-03-31	$448,583	6,124	-0.7%	Shares	Sole	2024-04-24
2023-12-31	$499,669	6,168	+0.8%	Shares	Sole	2024-01-03
2023-09-30	$458,557	6,119	+3.4%	Shares	Sole	2023-10-10
2023-06-30	$455,869	5,915	-5.7%	Shares	Sole	2023-07-25
2023-03-31	$520,470	6,273	-1.7%	Shares	Sole	2023-04-11
2022-12-31	$548,066	6,384	+0.8%	Shares	Sole	2023-01-11
2022-09-30	$390,867	6,336	+4.6%	Shares	Sole	2022-10-12
2022-06-30	$374,444	6,058	+0.8%	Shares	Sole	2022-07-12
2022-03-31	$357,175	6,008	+4.0%	Shares	Sole	2022-04-20
2021-12-31	$419,540	5,778	—	Shares	Sole	2022-01-25
No filing history on record for this holder in this stock.